secwatch / observer
8-K filed May 1, 2025, 7:59 PM ET ticker PTHS CIK 0001919246
regulatory confidence medium sentiment negative materiality 0.20

Channel Therapeutics issues NYSE American-required announcement on going concern in 2024 10-K

Pelthos Therapeutics Inc.

item 7.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001753926-25-000722
form_type
8-K
ticker
PTHS
cik
0001919246
company_name
Pelthos Therapeutics Inc.
filed_at
2025-05-01T23:59:59+00:00
discovered_at
2026-05-14T18:02:50.468296+00:00
generated_at
2026-05-23T01:12:24.251147+00:00
sec_items
["7.01", "9.01"]
event_type
regulatory
sentiment
negative
materiality_score
0.2
calibrated_materiality_score
0.2
confidence
medium
secwatch_canonical_url
https://secwatch.observer/filing/0001753926-25-000722
json_url
https://secwatch.observer/filing/0001753926-25-000722.json
markdown_url
https://secwatch.observer/filing/0001753926-25-000722.md
text_url
https://secwatch.observer/filing/0001753926-25-000722.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1919246/000175392625000722/0001753926-25-000722-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1919246/000175392625000722/g084795_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Comparable filings

XCUR

Exicure gets Nasdaq delinquency notice for late 10-Q; files next day, says compliance regained

EXICURE, INC. June 1, 2026, 3:30 PM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

MSS

Maison Solutions regains Nasdaq minimum bid price compliance; listing continues

Maison Solutions Inc. May 12, 2026, 1:22 PM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

CLIR

ClearSign Technologies suspends ATM prospectus supplement for $10.39 million common stock offering; no shares sold

ClearSign Technologies Corp May 28, 2026, 4:19 PM ET regulatory Items 8.01, 9.01

same SEC item: 9.01 same event type: regulatory similar materiality

Filing page SEC filing

BVS

Bioventus Exogen device reclassified by FDA, CMS updates reimbursement rates; company reiterates 2026 guidance

Bioventus Inc. May 21, 2026, 4:58 PM ET regulatory Items 7.01

same SEC item: 7.01 same event type: regulatory similar materiality

Filing page SEC filing

AIRE

reAlpha regains Nasdaq minimum bid price compliance; matter closed

reAlpha Tech Corp. May 14, 2026, 4:20 PM ET regulatory Items 8.01, 9.01

same SEC item: 9.01 same event type: regulatory similar materiality

Filing page SEC filing

GENC

Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing

GENCOR INDUSTRIES INC June 1, 2026, 4:09 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory

Filing page SEC filing

NJR

NJNG files base rate case seeking $157.6M increase; offers 8.9% winter bill cut

NEW JERSEY RESOURCES CORP June 1, 2026, 4:03 PM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory

Filing page SEC filing

ELTP

Elite Pharmaceuticals files ANDA for generic anticoagulant; $26B brand market, no generic available

ELITE PHARMACEUTICALS INC /NV/ June 1, 2026, 7:00 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory

Filing page SEC filing

Source: SEC EDGAR
accession 0001753926-25-000722
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.